Evaluates dose variability in paediatric dosing through tablet splitting, suggesting implications for prescribing practices.
Objectives To evaluate the accuracy of tablet splitting for paediatric dosing by assessing mass and content uniformity. Methods Whole, half, and quarter tablets of mercaptopurine, azathioprine, and spironolactone were prepared using a manual tablet splitter. Fragment mass and quarter-tablet drug content were assessed against European Pharmacopoeia criteria. Key findings Split fragments showed high variability (coefficient of variation 8.6%–23.3%). Most failed European Pharmacopoeia mass uniformity criteria. Content analysis revealed only 50%–70% of quarters complied with acceptance limits, with ranges of 52%–133% of claim. Conclusions Tablet splitting introduces substantial dose variability undetectable by weighing alone. Where possible, low-strength tablets or alternative formulations should be preferred.
No takes yet. Share an insight, caveat, or question.
Hodkinson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: